Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Eslam Elkhadrawy on Heparin-Induced Thrombocytopenia
Eslam Elkhadrawy/LinkedIn
Jan 28, 2026, 11:45

Eslam Elkhadrawy on Heparin-Induced Thrombocytopenia

Eslam Elkhadrawy, Product Specialist at Inspire Pharma Egypt, shared on LinkedIn:

”Heparin-Induced Thrombocytopenia (HIT):

When anticoagulation paradoxically causes thrombosis

HIT is a severe immune-mediated adverse drug reaction in which heparin exposure leads to thrombocytopenia accompanied by a high risk of thrombosis, rather than bleeding.

The condition is driven by IgG antibodies against the heparin–platelet factor 4 (PF4) complex, resulting in platelet activation and excessive thrombin generation.

Key message:
In HIT, thrombocytopenia reflects platelet activation and consumption, not impaired hemostasis.

References
Greinacher A. NEJM, 2015
Warkentin TE. Circulation, 2015”

Stay updated with Hemostasis Today.

Eslam Elkhadrawy Health Hematology Hemostasis Hemostasis News Hemostasis Today Heparin HIT Medicine thrombosis
NewsFeed